Bortezomib is a medication used in the treatment of multiple myeloma and mantle cell lymphoma. It belongs to a class of drugs known as proteasome inhibitors. The proteasome is a cellular structure responsible for breaking down proteins, including those involved in cell cycle regulation and cell survival. By inhibiting the proteasome, bortezomib disrupts the normal processes within cancer cells, leading to their death.
Bortezomib is commonly used in the treatment of multiple myeloma, a cancer of plasma cells in the bone marrow. Bortezomib is also approved for the treatment of mantle cell lymphoma, a type of non-Hodgkin lymphoma.
Buy Bortezomib impurities from Simson Pharma Limited at best competitive price. Every compound produced by Simson Pharma is accompanied by Certificate of Analysis